About Safex Chemicals IPO
Safex Chemicals (India) IPO Details
Safex Chemicals (India) IPO is a 100% book-built issue, comprising a fresh issue of ₹450 crore and an offer for sale (OFS) of 3.57 crore equity shares, with a face value of ₹1 per share. The company filed its DRHP on July 3, 2025.
The price band and official dates of subscription and listing will be announced by the company later, but the shares are supposed to be listed on the BSE and the NSE platforms. The book-running lead managers of this issue are Axis Capital Ltd., JM Financial Ltd. and SBI Capital Markets Ltd., while the registrar to the issue is KFin Technologies Ltd.
Safex Chemicals (India) IPO Date & Timeline
Safex Chemicals (India) Ltd. officially filed its Draft Red Herring Prospectus (DRHP) on July 3, 2025. However, the specific Safex Chemicals (India) IPO date and subscription timeline remain unannounced. Following regulatory approval, the company will finalise the price band and bidding dates. Once cleared, the schedule for anchor allotment, public bidding and the final listing on the exchange will be formally disclosed.
Safex Chemicals IPO Timeline
| IPO Open Date | - |
| IPO Close Date | - |
| Tentative Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Tentative Listing Date | - |
| Cut-off time for UPI mandate confirmation | - |
Safex Chemicals IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹ 1 per share |
| Issue Price Band | - |
| Lot Size | - |
| Sale Type | Fresh Capital & OFS |
| Total Issue Size | - |
| Fresh Issue(Ex Market Maker) | [.] shares (agg. up to ₹ 450 Cr) |
| Offer for Sale | 3,57,34,818 shares of ₹1 (agg. up to ₹[.] Cr) |
| Net Offered to Public | - |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 16,05,85,503 shares |
| Share Holding Post Issue | - |
Safex Chemicals (India) IPO GMP (Grey Market Premium)
“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.
The Safex Chemicals (India) IPO GMP is currently trading at ₹[.], reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.
Company Background
Safex Chemicals (India) was incorporated in January 1991 in New Delhi. Over 30 years, the company has grown from branded agrochemical formulations into a diversified speciality chemicals entity. It has expanded through organic growth and strategic acquisitions, including Shogun Organics in 2021 and UK-based Briar Chemicals in 2022.
The company is engaged in the chemical industry, focusing on agrochemicals with a different business model. They operate in 3 different verticals, catering to the needs of farmers and mainly aim to help increase crop productivity by providing a wide range of crop protection products. Currently, Safex operates as an integrated player with a footprint spanning 22 countries across six continents.
Operations & Product Range
Safex Chemicals (India) Ltd. operates through three key business verticals: Branded Formulations, Speciality Chemicals, and CDMO. The vertical of Branded Formulations boasts 140 different products that range from insecticides, herbicides, fungicides, to plant growth regulators. The speciality chemical segment comprises products in technical grade forms as opposed to formulations. On the other hand, the CDMO vertical entails contract manufacturing for agrochemical majors such as Bayer AG.
Facilities & Capacity
Safex Chemicals (India) Ltd. operates 8 specialised manufacturing facilities, of which 7 are located within India's agrochemical hubs in Bahadurgarh (Haryana), Una (Himachal Pradesh) and Pune (Maharashtra) and the 8th is a 115-acre campus in Norwich, United Kingdom, serving as the hub for international CDMO operations. These facilities are supported by quality control and process safety operations and a dedicated workforce of over 1,500 full-time employees as of March 2025.
Brands & Market Presence
Safex Chemicals (India) Ltd. has built a formidable market presence through a unique multi-brand strategy utilizing brands such as Safex, IndoSwiss and Smith N Smith to cater to different market segments. Domestic presence is supported by a pan-India distribution network of over 14,950 active dealers. Internationally, nearly 29% of FY25 revenue was derived from overseas markets across 22 countries. Its proprietary mosquito repellent molecule, "Renofluthrin" has further enhanced its brand reputation as an innovator in the household insecticide space.
Revenue Streams & Business Model
The primary revenue channel of Safex Chemicals (India) Ltd. is generated through branded formulations, technical ingredients and specialised CDMO service contracts. In FY25, branded formulations accounted for 62.47% of consolidated revenue, the CDMO segment contributed 27.01% and speciality chemicals approximately 17.30% (before inter-segment eliminations). This diversified revenue mix mitigates seasonal risks inherent in the agrochemical industry, while backward integration into technical manufacturing provides control over raw material quality and costs.
Management & Shareholding
Safex Chemicals (India) Ltd. is promoted by Neeraj Kumar Jindal, Piyush Jindal, Rajesh Kumar Jindal and Surinder Kumar Chaudhary. Before the IPO, the promoter held 37.97% and the promoter group held 16.33%; together, they held the 54.30% stake in the company, but after the IPO, the promoters and promoter group will face a minor dilution as the offering consists of 3.57 crore OFS by existing shareholders.
Board & Key Management
The leadership of Safex Chemicals (India) Ltd. is led by a team of experts with many years of experience. Surinder Kumar Chaudhary serves as the Chairman and gives strategic direction to the firm. The daily operations are managed by Neeraj Kumar Jindal, the Managing Director. To ensure good governance, the board includes Independent Directors Prem Chand, Yogesh Kapur, Savan Rashmikant Godiawala, Bipinchandra Solanki and Manisha Raghunath Kadagathur for honest oversight. Together, this team uses its knowledge to help the company grow and stay successful.
Safex Chemicals IPO Financial Information
Latest Revenue
₹ 1,605.82 Cr
Profit After Tax
₹ -14.29 Cr
Net Worth
₹ 611.46 Cr
Total Borrowing
₹ 830.39 Cr
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 2025 | 2,084.36 | 1,605.82 | -14.29 | 611.46 | 656.47 | 830.39 |
| 31 Mar 2024 | 1,923.43 | 1,417.66 | -22.79 | 626.15 | 657.8 | 677.09 |
| 31 Mar 2023 | 1,905.17 | 1,167.47 | -1.02 | 648.88 | 664.85 | 680.22 |
| Amount in ₹ Crore | ||||||
Safex Chemicals Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | -2.12% |
| ROCE | 10.65% |
| Debt/Equity | 0.95x |
| RoNW | -2.34% |
| PAT Margin | -0.90% |
| EBITDA Margin | 14.70% |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | -0.89 | -0.89 |
| P/E (x) | - | - |
Safex Chemicals (India) IPO Objectives
The company intends to utilise the Safex Chemicals (India) IPO proceeds for strategic purposes:
- • Repayment or prepayment of debt of the parent company, as well as of its subsidiary
- • General corporate purposes
Safex Chemicals (India) IPO Review
Safex Chemicals (India) Ltd. is a speciality chemicals company with an emphasis on agrochemical products and operations along the entire value chain of agrochemicals. In addition, Safex was cited among the fastest-growing firms in the Indian agrochemical sector during fiscal years 2023 to 2025.
Financially, the revenue from operations was reported at ₹1,605.82 crore. However, the company reported a restated consolidated loss for the same period, attributed primarily to one-time charges including goodwill impairment and remediation provisions related to its UK subsidiary.
Risks include high exposure to raw material price volatility and the working capital-intensive nature of the agrochemical trade. Overall, the IPO offers an opportunity to invest in a scaled-up speciality chemicals player transitioning from a period of heavy inorganic expansion to financial consolidation.
Conclusion
The Safex Chemicals (India) IPO is an opportunity for investors to invest in a growing company that has successfully globalised its operations over the last decade. With a strong manufacturing base in India and the UK, a vast domestic distribution network and a clear focus on debt reduction. This issue aims to strengthen the balance sheet by reducing the debt and to fund the day-to-day operating expenses.
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The INDIA IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Business Model Diversification with operations in all three verticals, including branded products, speciality products and CDMO agrochemicals.
Multi-branded strategy with the backing of an extensive network of 15,000 dealers across the entire nation of India.
Wide global footprint with operations in 22 countries and a manufacturing facility in the UK.
Competitive product development with the launch of a unique product like Renofluthrin.
| Sr.no | Description | Date | File |
|---|---|---|---|
| 1 | SEBI/Exchange approval received | 17/10/2025 | - |
| 2 | Filed with SEBI/Exchange | 04/07/2025 | View DRHP |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | — | ~₹14,000 - ₹ 15,000 |
| Individual investors (Retail) (Max) | 13-14 | — | Up to ₹ 2,00,000 |
| S-HNI (Min) | 14-15 | — | Over ₹2,00,000 |
| S-HNI (Max) | 66-70 | — | Up to ₹ 10,00,000 |
| B-HNI (Min) | 71+ | — | Over ₹10,00,000 |